Richard Simcock (@breastdocuk) 's Twitter Profile
Richard Simcock

@breastdocuk

Chief Medical Officer @macmillancancer NHS Breast Cancer Oncologist / Honorary Professor @UHSussex, #radonc #BHAFC #gerionc (He/Him) #Brighton Also on Bluesky

ID: 388471366

linkhttp://www.radiationnation.com calendar_today10-10-2011 20:05:04

12,12K Tweet

6,6K Followers

1,1K Following

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

People with cancer need health information that is trusted and true. At Macmillan Cancer Support we are proud to have a quality tick from the independent Patient Information Forum Here they are calling out misinformation: youtu.be/OpCXnDvDJCo?si… via YouTube

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

Has Vivek Patel just presented the cheapest trial #ASCO25? <$500 to show that specific podcasts improve education for oncology fellows Also trainees can do incredible self-directed research.

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

At #ASCO25 we have heard how AI reduces workload, detects cancer, improves education and clinical trial recruitment and can correctly define protein structures in minutes. There has been less mention of AI’s powerful advice not to wear board shorts to the conference…

At #ASCO25 we have heard how AI reduces workload, detects cancer, improves education and clinical trial recruitment and can correctly define protein structures in minutes.

There has been less mention of AI’s powerful advice not to wear board shorts to the conference…
Richard Simcock (@breastdocuk) 's Twitter Profile Photo

At #ASCO25 just days after RFK Jnr says that major medical journals are "corrupt", the issue of trust in science feels vitally important. This poster paints a depressing picture - not least in that Americans distinguish 'doctors' from 'scientists' "Trust is fading" . Indeed

At #ASCO25 just days after RFK Jnr says that major medical journals are "corrupt", the issue of trust in science feels vitally important.

This poster paints a depressing picture - not least in that Americans distinguish 'doctors' from 'scientists'

"Trust is fading" . Indeed
ASCO (@asco) 's Twitter Profile Photo

Live from #ASCO25! I'm Andrea Anampa-Guzmán (she/ella) taking over the ASCO account. Join us in S100bc for “AI, Improving Cancer Care, and the Future of Collaboration,” featuring Google Cloud CEO Thomas Kurian & ASCO CEO Dr. Clifford Hudis

Live from #ASCO25! I'm <a href="/AndreaAnampaG/">Andrea Anampa-Guzmán (she/ella)</a>  taking over the ASCO account. Join us in S100bc for “AI, Improving Cancer Care, and the Future of Collaboration,” featuring <a href="/googlecloud/">Google Cloud</a>  CEO Thomas Kurian &amp; ASCO CEO Dr. <a href="/CliffordHudis/">Clifford Hudis</a>
Pramesh CS (@cspramesh) 's Twitter Profile Photo

Much deserved standing ovation for this presentation. Demonstrates 1. Research should ask questions that matter to patients 2. Global relevance (cost effectiveness, implementability) matter 3. Academic research groups can achieve a lot Why wasn't this at the ASCO plenary?

Much deserved standing ovation for this presentation. Demonstrates
1. Research should ask questions that matter to patients
2. Global relevance (cost effectiveness, implementability) matter
3. Academic research groups can achieve a lot
Why wasn't this at the <a href="/ASCO/">ASCO</a> plenary?
Prof. Haryana Dhillon (@hagsie) 's Twitter Profile Photo

Adan Z Becerra, PhD Aaron Goodman - “Papa Heme” If this trial does not change practice it will be on oncology community. We provided structured exercise program supported by intervention manual & behaviour change support tools. We trained exercise consultants & provided ongoing supervision. It is absolutely scalable #ASCO25

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

Yet another reassuring data point that vaginal estrogens are safe after #breastcancer 800 women all over 65 compared to 17820 with no vaginal estrogen No survival detriment (a benefit possibly due to survivor bias) #ASCO25

Yet another reassuring data point that vaginal estrogens are safe after #breastcancer

800 women all over 65 compared to 17820 with no vaginal estrogen

No survival detriment (a benefit possibly due to survivor bias)
#ASCO25
Jonathan Reiner (@jreinermd) 's Twitter Profile Photo

RFK Jr has fired all 17 members of CDC’s Advisory Committee for Immunization Practices. The US now has no CDC director and no ACIP. Control of US vaccines is concentrated in the office of an HHS Sec who doesn’t believe any vaccine is safe and effective. wsj.com/opinion/rfk-jr…

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

Swedish Medical students frequently use generative AI in their studies, but very little use of podcasts (they're missing out) Digital learning resource use among Swedish medical students: insights from a nationwide survey | BMC Medical Education | Full Text

Swedish Medical students frequently use generative AI in their studies, but very little use of podcasts (they're missing out)

Digital learning resource use among Swedish medical students: insights from a nationwide survey | BMC Medical Education | Full Text
Sussex Cancer Fund (@sxcancerfund) 's Twitter Profile Photo

Dr Jo Stokoe, Consultant Oncologist at the Sussex Cancer Centre, is currently swimming the North Channel! 🏊‍♀️🌊 One of the world’s toughest swims, she's raising funds incl. for SCF. Support Jo: 👉 bit.ly/40dxuzN #TeamJo #NorthChannelSwim

Dr Jo Stokoe, Consultant Oncologist at the Sussex Cancer Centre, is currently swimming the North Channel! 🏊‍♀️🌊 One of the world’s toughest swims, she's raising funds incl. for SCF. Support Jo:
👉 bit.ly/40dxuzN
#TeamJo #NorthChannelSwim
Richard Simcock (@breastdocuk) 's Twitter Profile Photo

My Oncologist colleague Jo Stokoe is *right now* currently aiming to be the 165th person to swim the North Channel. No wetsuit Lions Mane jellyfish And all in aid of the RNLI and Sussex Cancer Fund Donate here: justgiving.com/team/jos-north…

Richard Simcock (@breastdocuk) 's Twitter Profile Photo

More than half a million patients, 791 Phase 3 trials and only *6%* of them led to an improvement in overall survival and quality of life Trial design and regulatory endpoints are the levers for change. jamanetwork.com/journals/jamao…

More than half a million patients, 791 Phase 3 trials and only *6%* of them led to an improvement in overall survival and quality of life

Trial design and regulatory endpoints are the levers for change.

jamanetwork.com/journals/jamao…
Richard Simcock (@breastdocuk) 's Twitter Profile Photo

A shocking and tragic story of a death that may have been avoided Well done to Tom Roques and Dr Liz O'Riordan for speaking so well on truth and the dangers of misinformation